This may be supported by the fact that normal cells from MEN1 patients present an elevated level of chromosome alterations [57-60] and that MEN1 tumours have more genome aberrations than equivalent tumours from non-MEN1 patients [61]. The gene discussed is MEN1; the disease is neoplasm.